Job F M van Boven is an expert in Pulmonology at University Medical Center Groningen (Netherlands). As of October 2026, ScienceLeadR ranks Job F M van Boven in the top 1% of experts worldwide for Asthma, Hypersensitivity and Lung Diseases, Obstructive. Job F M van Boven has authored 243 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 3 of them ongoing. SLR score: 943 (community average: 125). How the SLR is computed.

LeadR Profile

Job F M van Boven University Medical Center Groningen Netherlands
943 ScienceLeadR Reputation 943
Network Map

Pulmonology

Subspecialties: Pharmacy - Immunology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026

Source: PubMed

University Medical Center Groningen

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 243

Citations

Citations: 40 880 1st author: 42 Last author: 50 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 6
Phase 4 1

By status:

Completed 3
Recruiting 3
Unknown 1

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 2
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Inhaler Adherence and Inhalation Technique Assessed by a Smart Spacer in Patients with Severe Asthma on Biologics
NCT06360393 — inhalation, respiratory aspiration, medication adherence, therapeutics, asthma, biological therapy
N/ARecruiting2024
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
NCT05525338 — cells, genes, lung, pharmaceutical preparations, lymphoma, neoplasms, drug monitoring, carcinoma, non-small-cell lung, lung neoplasms, therapeutics, anaplastic lymphoma kinase, mutation, carcinoma
Phase 4Recruiting2022
Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease
NCT05495698 — chronic disease, lung, multiple chronic conditions, pulmonary disease, chronic obstructive, medication adherence, therapeutics, lung diseases, lung diseases, obstructive
N/ARecruiting2022

LeadR Networks

Main global connection map